BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33057626)

  • 1. A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell Carcinoma.
    Liu X; Liu P; Chernock RD; Yang Z; Lang Kuhs KA; Lewis JS; Luo J; Li H; Gay HA; Thorstad WL; Wang X
    J Natl Cancer Inst; 2021 Jun; 113(6):752-759. PubMed ID: 33057626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic gene expression signature for oropharyngeal squamous cell carcinoma.
    Liu X; Liu P; Chernock RD; Kuhs KAL; Lewis JS; Luo J; Gay HA; Thorstad WL; Wang X
    EBioMedicine; 2020 Nov; 61():102805. PubMed ID: 33038770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
    Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
    Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-182-5p and microRNA-205-5p as potential biomarkers for prognostic stratification of p16-positive oropharyngeal squamous cell carcinoma.
    Weiss BG; Anczykowski MZ; Ihler F; Bertlich M; Spiegel JL; Haubner F; Canis M; Küffer S; Hess J; Unger K; Kitz J; Jakob M
    Cancer Biomark; 2022; 33(3):331-347. PubMed ID: 34542062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Worakitchanon W; Panvongsa W; Siripoon T; Kitdumrongthum S; Wongpan A; Arsa L; Trachu N; Jinawath N; Chairoungdua A; Ngamphaiboon N
    JCO Precis Oncol; 2023 May; 7():e2300003. PubMed ID: 37163716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
    De Ruyck K; Duprez F; Ferdinande L; Mbah C; Rios-Velazquez E; Hoebers F; Praet M; Deron P; Bonte K; Speel EJ; Libbrecht L; De Neve W; Lambin P; Thierens H
    Cancer Epidemiol; 2014 Oct; 38(5):591-8. PubMed ID: 25127693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection.
    Hess J; Unger K; Maihoefer C; Schüttrumpf L; Wintergerst L; Heider T; Weber P; Marschner S; Braselmann H; Samaga D; Kuger S; Pflugradt U; Baumeister P; Walch A; Woischke C; Kirchner T; Werner M; Werner K; Baumann M; Budach V; Combs SE; Debus J; Grosu AL; Krause M; Linge A; Rödel C; Stuschke M; Zips D; Zitzelsberger H; Ganswindt U; Henke M; Belka C
    Clin Cancer Res; 2019 Mar; 25(5):1505-1516. PubMed ID: 30171046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross validated serum small extracellular vesicle microRNAs for the detection of oropharyngeal squamous cell carcinoma.
    Mayne GC; Woods CM; Dharmawardana N; Wang T; Krishnan S; Hodge JC; Foreman A; Boase S; Carney AS; Sigston EAW; Watson DI; Ooi EH; Hussey DJ
    J Transl Med; 2020 Jul; 18(1):280. PubMed ID: 32650803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
    Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
    Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
    J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Khwaja SS; Baker C; Haynes W; Spencer CR; Gay H; Thorstad W; Adkins DR; Nussenbaum B; Chernock RD; Lewis JS; Wang X
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1132-41. PubMed ID: 27209503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
    Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G
    Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.
    Miller DL; Davis JW; Taylor KH; Johnson J; Shi Z; Williams R; Atasoy U; Lewis JS; Stack MS
    Am J Pathol; 2015 Mar; 185(3):679-92. PubMed ID: 25572154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.